IBDEI1YP ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33301,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,33301,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,33301,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,33302,0)
 ;;=L25.9^^131^1669^115
 ;;^UTILITY(U,$J,358.3,33302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33302,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,33302,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,33302,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,33303,0)
 ;;=L26.^^131^1669^148
 ;;^UTILITY(U,$J,358.3,33303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33303,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,33303,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,33303,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,33304,0)
 ;;=L27.0^^131^1669^265
 ;;^UTILITY(U,$J,358.3,33304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33304,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,33304,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,33304,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,33305,0)
 ;;=L27.1^^131^1669^266
 ;;^UTILITY(U,$J,358.3,33305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33305,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,33305,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,33305,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,33306,0)
 ;;=L29.0^^131^1669^250
 ;;^UTILITY(U,$J,358.3,33306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33306,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,33306,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,33306,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,33307,0)
 ;;=L29.9^^131^1669^251
 ;;^UTILITY(U,$J,358.3,33307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33307,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,33307,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,33307,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,33308,0)
 ;;=L30.0^^131^1669^232
 ;;^UTILITY(U,$J,358.3,33308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33308,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,33308,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,33308,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,33309,0)
 ;;=L30.1^^131^1669^140
 ;;^UTILITY(U,$J,358.3,33309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33309,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,33309,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,33309,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,33310,0)
 ;;=L30.2^^131^1669^132
 ;;^UTILITY(U,$J,358.3,33310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33310,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,33310,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,33310,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,33311,0)
 ;;=L30.4^^131^1669^144
 ;;^UTILITY(U,$J,358.3,33311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33311,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,33311,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,33311,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,33312,0)
 ;;=L30.8^^131^1669^135
 ;;^UTILITY(U,$J,358.3,33312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33312,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,33312,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,33312,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,33313,0)
 ;;=L30.9^^131^1669^136
 ;;^UTILITY(U,$J,358.3,33313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33313,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,33313,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,33313,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,33314,0)
 ;;=L40.0^^131^1669^253
 ;;^UTILITY(U,$J,358.3,33314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33314,1,3,0)
 ;;=3^Psoriasis Vulgaris
